Saint Petersburg, Florida Mar 5, 2026 (Issuewire.com) - Disseminated on behalf of MindBio Therapeutics
What This Company Does
MindBio built an AI model trained on 50+ million voice data points from clinical drug and alcohol trials. The technology analyzes short voice samples to predict intoxication levels in real time, no hardware, no blood draw, no breathalyzer. The consumer app (Booze AI) launched in 2025 as the first voice-activated blood alcohol estimator on smartphones. The company is now developing enterprise versions for workplaces, mining, law enforcement, and healthcare.
Why It Matters
Traditional impairment testing is invasive, expensive, and episodic. Voice-based detection is software-only, scalable, and can be deployed remotely. If the accuracy holds in commercial environments, this addresses massive markets: workplace safety compliance, road safety, addiction treatment monitoring, and insurance risk. The company announced on February 18, 2026 that it is building a dedicated Edge AI hardware device for the mining sector, with Chile as its first target market and prototype completion expected Q2 2026. Each device would carry recurring software revenue.
Leadership Highlights
Chairman Gavin Upiter founded Generic Health (sold to Lupin Pharmaceuticals), served as Australian CEO of Amneal Pharmaceuticals (NYSE: AMRX), and held executive roles at Bristol-Myers Squibb and Slade Health. CEO Justin Hanka is an investment banker and co-founder who remains a significant shareholder.
Recent Milestones
Date
Event
Jan 2025
Discovered speech-based intoxication detection from clinical trial data; LOI to acquire Life AI Corp
Mar 2025
Closed acquisition of Life AI Corp and Booze AI application
May 2025
Completed Booze AI software development; prepared for consumer launch
Nov 2025
400:1 share consolidation approved and completed via CSE
Jan 2026
Listed on OTCQB; launched US showcase of voice AI detection tech
Feb 2026
Announced Edge AI hardware platform for mining; initiated Chile operations
For more information visit: https://mindbiotherapeutics.com
https://www.tradingview.com/news/reuters.com%2C2026-02-18%3Anewsml_Tnw971MHZ%3A0-mindbio-advances-large-scale-deployment-of-voice-intoxication-detection-through-integrated-edge-ai-hardware-software-platform/
Sponsored Article
by Street Scope Media, LLC
Communicated Disclaimer
Media Contact
Street Scope Media LLC contact@streetscopemedia.com 3214416545 30 N Gould st http://www.streetscopemedia.com
